Effect of Single-task, Dual-task and Analogy Training During Gait Rehabilitation
NCT03811782, Not applicable, Unknown, The University of Hong Kong
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Single-task, Dual-task and Analogy Training During Gait Rehabilitation | ClinicalTrials.gov |
| NCT number | NCT03811782 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 105 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | The University of Hong Kong | ClinicalTrials.gov |
| Conditions | Fall, Balance, Reinvestment Propensity, Gait Rehabilitation | ClinicalTrials.gov |
| Interventions | Single-task Training, Dual-task Training, Analogy Training | ClinicalTrials.gov |
| First posted | 2019-01-22 | ClinicalTrials.gov |
| Last updated | 2020-03-25 | ClinicalTrials.gov |
Registered outcomes 23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Baseline propensity for conscious motor processing | Before the start of training | The Chinese version Movement Specific Reinvestment Scale (MSRS-C) (Masters et al., 2005; Wong et al., 2015a; Wong et al., 2015b). The MSRS-C includes two sub-scales: Conscious motor processing and Movement self-consciousness. The scores for both sub-scales ranges from 5-30. A higher score indicate a higher propensity for conscious motor processing. | ClinicalTrials.gov |
| Primary | Change from baseline propensity for conscious motor processing upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | The Chinese version Movement Specific Reinvestment Scale (MSRS-C) (Masters et al., 2005; Wong et al., 2015a; Wong et al., 2015b). The MSRS-C includes two sub-scales: Conscious motor processing and Movement self-consciousness. The scores for both sub-scales ranges from 5-30. A higher score indicate a higher propensity for conscious motor processing. | ClinicalTrials.gov |
| Primary | Change from baseline propensity for conscious motor processing at 6 months after the completion of training | 6 months after the completion of Training | The Chinese version Movement Specific Reinvestment Scale (MSRS-C) (Masters et al., 2005; Wong et al., 2015a; Wong et al., 2015b). The MSRS-C includes two sub-scales: Conscious motor processing and Movement self-consciousness. The scores for both sub-scales ranges from 5-30. A higher score indicate a higher propensity for conscious motor processing. | ClinicalTrials.gov |
| Secondary | Baseline single-task walking ability | Before the start of training | 10 meters comfortable and fast walking speed (Bohannon, 1997) | ClinicalTrials.gov |
| Secondary | Change from baseline single-task walking ability upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | 10 meters comfortable and fast walking speed (Bohannon, 1997) | ClinicalTrials.gov |
| Secondary | Change from baseline single-task walking ability at 6 months after the completion of training | 6 months after the completion of Training | 10 meters comfortable and fast walking speed (Bohannon, 1997) | ClinicalTrials.gov |
| Secondary | Baseline dual-task walking ability | Before the start of training | 10 meters comfortable and fast walking speed with concurrent verbal or visual-spatial dual-tasks of auditory stroop task (Siu, Catena, Chou, van Donkelaar, \& Woollacott, 2008) or clock test (Plummer-D'Amato, Altmann, Saracino, Fox, Behrman, \& Marsiske, 2008) | ClinicalTrials.gov |
| Secondary | Change from baseline dual-task walking ability upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | 10 meters comfortable and fast walking speed with concurrent verbal or visual-spatial dual-tasks of auditory stroop task (Siu, Catena, Chou, van Donkelaar, \& Woollacott, 2008) or clock test (Plummer-D'Amato, Altmann, Saracino, Fox, Behrman, \& Marsiske, 2008) | ClinicalTrials.gov |
| Secondary | Change from baseline dual-task walking ability at 6 months after the completion of training | 6 months after the completion of Training | 10 meters comfortable and fast walking speed with concurrent verbal or visual-spatial dual-tasks of auditory stroop task (Siu, Catena, Chou, van Donkelaar, \& Woollacott, 2008) or clock test (Plummer-D'Amato, Altmann, Saracino, Fox, Behrman, \& Marsiske, 2008) | ClinicalTrials.gov |
| Secondary | Baseline Tinetti Balance Assessment Tool score | Before the start of training | Tinetti Balance Assessment Tool (Tinetti, 1986). | ClinicalTrials.gov |
| Secondary | Change from baseline Tinetti Balance Assessment Tool score upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | Tinetti Balance Assessment Tool (Tinetti, 1986) | ClinicalTrials.gov |
| Secondary | Change from baseline Tinetti Balance Assessment Tool score at 6 months after the completion of training | 6 months after the completion of Training | Tinetti Balance Assessment Tool (Tinetti, 1986) | ClinicalTrials.gov |
| Secondary | Baseline Timed 'Up & Go' Tests time | Before the start of training | Timed 'Up \& Go' Tests (TU\&G(Podsiadlo \& Richardson, 1991) | ClinicalTrials.gov |
| Secondary | Change from baseline Timed 'Up & Go' Tests time upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | Timed 'Up \& Go' Tests (TU\&G(Podsiadlo \& Richardson, 1991) | ClinicalTrials.gov |
| Secondary | Change from baseline Timed 'Up & Go' Tests time at 6 months after the completion of training | 6 months after the completion of Training | Timed 'Up \& Go' Tests (TU\&G(Podsiadlo \& Richardson, 1991) | ClinicalTrials.gov |
| Secondary | Baseline Berg Balance Scale score | Before the start of training | Berg Balance Scale (BBS) (Berg, Wood Dauphinee, Williams \& Gayton, 1989) | ClinicalTrials.gov |
| Secondary | Change from baseline Berg Balance Scale score upon completion of training | Upon completion of 12 Training Sessions (4 weeks of training) | Berg Balance Scale (BBS) (Berg, Wood Dauphinee, Williams \& Gayton, 1989) | ClinicalTrials.gov |
| Secondary | Change from baseline Berg Balance Scale score at 6 months after the completion of training | 6 months after the completion of Training | Berg Balance Scale (BBS) (Berg, Wood Dauphinee, Williams \& Gayton, 1989) | ClinicalTrials.gov |
| Secondary | Cognitive function | Before the start of training | The Chinese version Mini-Mental State Examination (MMSE-C) (Folstein et al., 1975; Chiu et al., 1994). A mark of 24 or above out of 30 is required to meet the inclusion criteria. | ClinicalTrials.gov |
| Secondary | Baseline fear of falling | Before the start of training | Fall Efficacy Scale (FES-13) (Tinetti, Richman, \& Powell L, 1990; Tinetti, Leon, Doucette \& Parker, 1994; Hellström \& Lindmark, 1999). The FES-13 score ranges from 16-64. A higher score indicates greater fear of falling. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)